SCHEMBL5147599

SCHEMBL5147599

NC(=O)c1nnsc1Nc1ccc(F)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ILK Q13418 3/20 0.73
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HTT P42858 1/20 0.43
TP53 P04637 1/20 0.43
TNIK Q9UKE5 4/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
GAK O14976 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39
FLT3 P36888 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
MARK1 Q9P0L2 1/20 0.39
STK17A Q9UEE5 1/20 0.39
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609331 0.86 ILK (0.57) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5149415 0.85 ILK (0.73) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5146289 0.85 ILK (0.73) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5147602 0.84 ILK (1.00) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5147711 0.84 ILK (0.68) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5146331 0.82 ILK (0.69) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5149440 0.81 ILK (0.68) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5147749 0.81 ILK (0.68) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5146290 0.80 ILK (0.66) ILKALDH1A1MAPTMEN1KMT2A
SCHEMBL5147927 0.79 ILK (0.77) ILKALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288556-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2007-10-30 US disclosed
US-7022702-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-04-04 US disclosed
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-01-12 US disclosed
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds DERMIRA (CANADA), INC. 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND1, CCND3 ILK 1286/4885ALDH1A1 1001/4885MAPT 4864/4885
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND3, ACIN1 ILK 2862/4885ALDH1A1 715/4885MAPT 4790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.